Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Robotic walking with added targeted vibration to improve post-stroke gait

Official title: The Potential of Robotic-Assisted Gait Training in a Rehabilitation Settin

Run by Ludwig Boltzmann Institute for Arthritis and Rehabilitation · NCT07529054 · Data updated 2026-11-12

This trial tests whether adding Vibramoov® vibration therapy to Lokomat® robotic gait training helps people after stroke walk better.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment40 (estimated)
SponsorLudwig Boltzmann Institute for Arthritis and Rehabilitation
Research network
Locations1 site (Gröbming, Styria)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedFebruary 2027
Study endsDecember 2027
Registry record updatedApril 14, 2026
Trial IDNCT07529054 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 at least 3 months after ischemic or hemorrhagic stroke with moderate walking impairment (e.g., 6MWT ≤ 200 m, FAC ≤ 4, BBS ≤ 49), adequate cognition (MMSE ≥ 24), and lower-extremity spasticity MAS 0–3 are the intended participants.

Probably not a fit

Patients with severe comorbidities or other disabilities that preclude gait training, uncontrolled medical conditions, very mild or very severe gait deficits outside the inclusion criteria, or insufficient cognition are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will compare Lokomat® robotic-assisted gait training combined with the Vibramoov® functional proprioceptive stimulation device versus Lokomat® training alone in patients undergoing a four-week neurological inpatient rehabilitation program. Vibramoov® delivers targeted vibratory stimuli to muscle-tendon junctions to activate proprioceptors and sensorimotor centers, while the Lokomat® provides repetitive, task-specific assisted treadmill walking. Participants meeting cognitive and mobility criteria will be randomly assigned to one of the two groups and will complete protocolized training during their inpatient stay. Outcomes include qualitative and quantitative gait parameters such as walking speed, step length, and broader gait biomechanics to determine whether the combined approach yields greater improvements.

Why it matters

Potential benefit: If successful, the combined approach could improve walking speed, step length, and overall gait quality, translating to better mobility and daily function for stroke survivors.

How similar studies have gone: Small pilot studies combining focal sensory or vibratory stimulation with gait training have shown promising but mixed results, and large definitive randomized trials are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of stroke (ischemic or hemorrhagic) ≥ 3 months
* Age ≥ 18a and ≤ 80a
* 6MWT ≤ 200m
* Barthel Index ≤ 95
* Mini Mental State Exam (MMSE) ≥ 24
* FAC: ≤ 4
* BBS): ≤49
* Modified Ashworth Scale (MAS): 0-3 for the lower extremity

Exclusion Criteria:

* The presence of any comorbidity or disability other than stroke that would preclude gait training
* Any uncontrolled health condition for which exercise is contraindicated

Where it's running

  • Reha-Zentrum Gröbming
    Gröbming, Styria, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • Stem cell therapy for chronic stroke recovery

    This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

    Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Morning-strength boost with caffeine or whole-body vibration

    This study tests whether taking 300 mg caffeine or using whole-body vibration helps healthy, regularly trained adults see improvements in morning strength and thinking skills.

    Recruiting Phase 4 Liverpool John Moores University · Liverpool, Merseyside · NCT07921810

  • Web-based therapy using action observation and mirror therapy for arm weakness after stroke

    This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.

    Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT07921108

  • Remote Ischaemic Conditioning for Fatigue After Stroke 2

    Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.

    Recruiting Phase 2 Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT07914647

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.